Alaunos Therapeutics (TCRT)

• Market cap: $2.37M
• 1 day: -1.33%
• 5 days: -2.63%
• 1 month: -8.64%
• 3 months: -22.11%
• 6 months: -36.48%
• Year to date: -24.87%
• 1 year: -90.92%
• 5 years: -99.56%
• 10 years: -99.93%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

Employees: 34

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 29 [Q3] → 30 (+1) [Q4]

7.5% less ownership

Funds ownership: 12.0% [Q3] → 4.51% (-7.5%) [Q4]

78% less capital invested

Capital invested by funds: $623K [Q3] → $138K (-$485K) [Q4]

83% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 12